MariMed’s Robust First-Quarter Performance Signals Growth Amidst Cannabis Market Competition
Analyst Zuanic Foresees Lucrative Tax Savings Potential for MariMed Amidst Strategic Expansion Plans
According to benzinga, MariMed is doing really well in the cannabis market, and analyst Zuanic thinks it could bring in more money than usual for investors. Even though there was a slight drop in sales compared to the previous quarter, MariMed did great in the first quarter of the year. Their sales went up by 10% compared to last year, especially in selling to other businesses, which went up by a huge 40%. This shows that even with lots of competition, MariMed is still growing and doing well.
One big advantage for MariMed is that they could save a lot of money on taxes because of a rule called 280E, especially if cannabis market gets moved to a different category. Zuanic thinks MariMed could save way more money in taxes than what their company is worth right now. Also, MariMed is planning to grow even more by getting more involved in how cannabis market is made and sold in places like Illinois, Maryland, and Massachusetts. This could make them even more money in the future.
Zuanic Bullish on MariMed: Urges Investors to Consider Buying Stock Amidst Promising Growth Prospects
Even though the price of MariMed’s stock has gone down recently, Zuanic thinks it doesn’t make sense because the company is doing so well financially and has big plans to grow. With some patience, people who invest in MariMed might make a lot of money, especially if they keep growing faster than other companies in the cannabis market. Zuanic is really optimistic about MariMed’s future and thinks it’s a good idea for people to buy their stock now before it becomes more expensive.